MORAN, EVA
MORAN, EVA
48 - Dipartimento di Medicina Interna e Specialita mediche (DIMI) (attivo dal 01/01/1997 al 18/07/2012)
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer
2011-01-01 Caffa, Irene; Soncini, Debora; Zoppoli, Gabriele; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs.
2012-01-01 Tortolina, Lorenzo; Castagnino, N; De Ambrosi, C; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Parodi, Silvio
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.
2011-01-01 Bello, C; Dal Bello, G; Cea, Michele; Nahimana, A; Aubry, D; Garuti, Anna; Motta, Giulia; Moran, Eva; Fruscione, Floriana; Pronzato, P; Grossi, F; Patrone, Franco; Ballestrero, Alberto; Dupuis, M; Sordat, B; Zimmermann, K; Loretan, J; Wartmann, M; Duchosal, Ma; Nencioni, Alessio; Vogel, P.
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS
2009-01-01 Cea, Mc; Cagnetta, Antonia; Garuti, Anna; Zoppoli, Gabriele; Rocco, Ilaria; Moran, Eva; Ballestrero, Alberto; Pierri, Ivana; Gobbi, Marco; Nencioni, Alessio; Patrone, Franco
APO866 activity in hematologic malignancies: a preclinical in vitro study.
2009-01-01 Cea, Michele; Zoppoli, Gabriele; Bruzzone, Santina; Fruscione, Floriana; Moran, Eva; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Casciaro, S; Olcese, F; Pierri, Ivana; Cagnetta, Antonia; Ferrando, Fabio; Ghio, Riccardo; Gobbi, Marco; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE
2009-01-01 Bruzzone, Santina; Fruscione, Floriana; Morando, Sara; Ferrando, Tiziana; Poggi, A.; Garuti, Anna; D'Urso, A.; Selmo, M.; Benvenuto, Federica; Cea, Michele; Zoppoli, Gabriele; Moran, Eva; Soncini, Debora; Ballestrero, Alberto; Sordat, B.; Patrone, Franco; Mostoslavsky, R.; Uccelli, Antonio; Nencioni, Alessio
Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer
2011-01-01 Caffa, Irene; Soncini, Debora; Zoppoli, Gabriele; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio
Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma.
2011-01-01 Motta, Giulia; Cea, Michele; Carbone, Federico; Augusti, Valeria; Moran, Eva; Patrone, Franco; Nencioni, Alessio
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis
2009-01-01 Uccelli, A; Bruzzone, S; Fruscione, F; Morando, S; Ferrando, T; Poggi, Alessandro; Garuti, A; Selmo, M; Benvenuto, F; Cea, M; Zoppoli, G; Moran, E; Vogel, P; Sordat, B; Ballestrero, A; Patrone, F; Nencioni, A
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression
2010-01-01 Nencioni, Alessio; Cea, Michele; Garuti, Anna; Passalacqua, Mario; Raffaghello, L.; Soncini, Debora; Moran, Eva; Zoppoli, Gabriele; Pistoia, V.; Patrone, Franco; Ballestrero, Alberto
Immunotherapy with dendritic cells for cancer
2008-01-01 Ballestrero, Alberto; Boy, D.; Moran, Eva; Cirmena, Gabriella; Brossart, P.; Nencioni, Alessio
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more.
2009-01-01 Cea, M; Cagnetta, Antonia; Garuti, Anna; Cirmena, Gabriella; Rocco, Ilaria; Moran, Eva; Grillo, V; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives.
2010-01-01 Motta, Giulia; Cea, Michele; Moran, Eva; Carbone, Federico; Augusti, Valeria; Patrone, Franco; Nencioni, Alessio
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.
2010-01-01 Bello, C; Cea, Michele; Bello, Gd; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Moran, Eva; Nahimana, A; Duchosal, Ma; Fruscione, Floriana; Pronzato, P; Grossi, F; Patrone, Franco; Ballestrero, Alberto; Dupuis, M; Sordat, B; Nencioni, Alessio; Vogel, P.
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients.
2010-01-01 Ballestrero, Alberto; Cirmena, Gabriella; Dominietto, A; Garuti, Anna; Rocco, Ilaria; Cea, Michele; Moran, Eva; Nencioni, Alessio; Miglino, Maurizio; Raiola, Am; Bacigalupo, A; Patrone, Franco
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
2009-01-01 Zoppoli, Gabriele; Cea, Michele; Fruscione, Floriana; Bruzzone, Santina; Soncini, Debora; Bedognetti, D.; Moran, Eva; Balleari, E.; Bruzzone, A.; Garuti, Anna; Cirmena, Gabriella; Rocco, Ilaria; Gobbi, Marco; Ghio, Riccardo; Pommier, Y.; Carella, A. M.; Ballestrero, Alberto; Parodi, Silvio; Patrone, Franco; Nencioni, Alessio
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells.
2010-01-01 Zoppoli, Gabriele; Cea, Michele; Soncini, Debora; Fruscione, Floriana; J., Rudner; Moran, Eva; Caffa, Irene; Bedognetti, Davide; Motta, Giovanni; Ghio, Riccardo; Ferrando, Fabio; Ballestrero, Alberto; Parodi, Silvio; C., Belka; Patrone, Franco; Bruzzone, Santina; Nencioni, Alessio
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience.
2012-01-01 Moran, Eva; Carbone, Federico; Augusti, Valeria; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio
Ras-induced resistance to lapatinib is overcome by MEK inhibition
2010-01-01 Zoppoli, Gabriele; Moran, Eva; Soncini, Debora; Cea, Michele; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Grillo, V; Bagnasco, Luca; Icardi, Giancarlo; Ansaldi, Filippo; Parodi, Silvio; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio
Selection of patients with high risk endometrial cancer for surgical staging according to the evaluation of pre- and intraoperative risk factors
2016-01-01 Sala, Paolo; Moran, Eva; Paolucci, Roberta; Menoni, Stefania; Fulcheri, Ezio; Costantini, Sergio; Valenzano Menada, Mario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer | 1-gen-2011 | Caffa, Irene; Soncini, Debora; Zoppoli, Gabriele; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio | |
| A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. | 1-gen-2012 | Tortolina, Lorenzo; Castagnino, N; De Ambrosi, C; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Parodi, Silvio | |
| Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. | 1-gen-2011 | Bello, C; Dal Bello, G; Cea, Michele; Nahimana, A; Aubry, D; Garuti, Anna; Motta, Giulia; Moran, Eva; Fruscione, Floriana; Pronzato, P; Grossi, F; Patrone, Franco; Ballestrero, Alberto; Dupuis, M; Sordat, B; Zimmermann, K; Loretan, J; Wartmann, M; Duchosal, Ma; Nencioni, Alessio; Vogel, P. | |
| ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS | 1-gen-2009 | Cea, Mc; Cagnetta, Antonia; Garuti, Anna; Zoppoli, Gabriele; Rocco, Ilaria; Moran, Eva; Ballestrero, Alberto; Pierri, Ivana; Gobbi, Marco; Nencioni, Alessio; Patrone, Franco | |
| APO866 activity in hematologic malignancies: a preclinical in vitro study. | 1-gen-2009 | Cea, Michele; Zoppoli, Gabriele; Bruzzone, Santina; Fruscione, Floriana; Moran, Eva; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Casciaro, S; Olcese, F; Pierri, Ivana; Cagnetta, Antonia; Ferrando, Fabio; Ghio, Riccardo; Gobbi, Marco; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio | |
| Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE | 1-gen-2009 | Bruzzone, Santina; Fruscione, Floriana; Morando, Sara; Ferrando, Tiziana; Poggi, A.; Garuti, Anna; D'Urso, A.; Selmo, M.; Benvenuto, Federica; Cea, Michele; Zoppoli, Gabriele; Moran, Eva; Soncini, Debora; Ballestrero, Alberto; Sordat, B.; Patrone, Franco; Mostoslavsky, R.; Uccelli, Antonio; Nencioni, Alessio | |
| Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer | 1-gen-2011 | Caffa, Irene; Soncini, Debora; Zoppoli, Gabriele; Moran, Eva; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio | |
| Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma. | 1-gen-2011 | Motta, Giulia; Cea, Michele; Carbone, Federico; Augusti, Valeria; Moran, Eva; Patrone, Franco; Nencioni, Alessio | |
| Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis | 1-gen-2009 | Uccelli, A; Bruzzone, S; Fruscione, F; Morando, S; Ferrando, T; Poggi, Alessandro; Garuti, A; Selmo, M; Benvenuto, F; Cea, M; Zoppoli, G; Moran, E; Vogel, P; Sordat, B; Ballestrero, A; Patrone, F; Nencioni, A | |
| Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression | 1-gen-2010 | Nencioni, Alessio; Cea, Michele; Garuti, Anna; Passalacqua, Mario; Raffaghello, L.; Soncini, Debora; Moran, Eva; Zoppoli, Gabriele; Pistoia, V.; Patrone, Franco; Ballestrero, Alberto | |
| Immunotherapy with dendritic cells for cancer | 1-gen-2008 | Ballestrero, Alberto; Boy, D.; Moran, Eva; Cirmena, Gabriella; Brossart, P.; Nencioni, Alessio | |
| Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. | 1-gen-2009 | Cea, M; Cagnetta, Antonia; Garuti, Anna; Cirmena, Gabriella; Rocco, Ilaria; Moran, Eva; Grillo, V; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio | |
| Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. | 1-gen-2010 | Motta, Giulia; Cea, Michele; Moran, Eva; Carbone, Federico; Augusti, Valeria; Patrone, Franco; Nencioni, Alessio | |
| Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. | 1-gen-2010 | Bello, C; Cea, Michele; Bello, Gd; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Moran, Eva; Nahimana, A; Duchosal, Ma; Fruscione, Floriana; Pronzato, P; Grossi, F; Patrone, Franco; Ballestrero, Alberto; Dupuis, M; Sordat, B; Nencioni, Alessio; Vogel, P. | |
| Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. | 1-gen-2010 | Ballestrero, Alberto; Cirmena, Gabriella; Dominietto, A; Garuti, Anna; Rocco, Ilaria; Cea, Michele; Moran, Eva; Nencioni, Alessio; Miglino, Maurizio; Raiola, Am; Bacigalupo, A; Patrone, Franco | |
| Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. | 1-gen-2009 | Zoppoli, Gabriele; Cea, Michele; Fruscione, Floriana; Bruzzone, Santina; Soncini, Debora; Bedognetti, D.; Moran, Eva; Balleari, E.; Bruzzone, A.; Garuti, Anna; Cirmena, Gabriella; Rocco, Ilaria; Gobbi, Marco; Ghio, Riccardo; Pommier, Y.; Carella, A. M.; Ballestrero, Alberto; Parodi, Silvio; Patrone, Franco; Nencioni, Alessio | |
| Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. | 1-gen-2010 | Zoppoli, Gabriele; Cea, Michele; Soncini, Debora; Fruscione, Floriana; J., Rudner; Moran, Eva; Caffa, Irene; Bedognetti, Davide; Motta, Giovanni; Ghio, Riccardo; Ferrando, Fabio; Ballestrero, Alberto; Parodi, Silvio; C., Belka; Patrone, Franco; Bruzzone, Santina; Nencioni, Alessio | |
| Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. | 1-gen-2012 | Moran, Eva; Carbone, Federico; Augusti, Valeria; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio | |
| Ras-induced resistance to lapatinib is overcome by MEK inhibition | 1-gen-2010 | Zoppoli, Gabriele; Moran, Eva; Soncini, Debora; Cea, Michele; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Grillo, V; Bagnasco, Luca; Icardi, Giancarlo; Ansaldi, Filippo; Parodi, Silvio; Patrone, Franco; Ballestrero, Alberto; Nencioni, Alessio | |
| Selection of patients with high risk endometrial cancer for surgical staging according to the evaluation of pre- and intraoperative risk factors | 1-gen-2016 | Sala, Paolo; Moran, Eva; Paolucci, Roberta; Menoni, Stefania; Fulcheri, Ezio; Costantini, Sergio; Valenzano Menada, Mario |